Unknown

Dataset Information

0

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.


ABSTRACT: Identification of voltage-gated sodium channel NaV1.7 inhibitors for chronic pain therapeutic development is an area of vigorous pursuit. In an effort to identify more potent leads compared to our previously reported GpTx-1 peptide series, electrophysiology screening of fractionated tarantula venom discovered the NaV1.7 inhibitory peptide JzTx-V from the Chinese earth tiger tarantula Chilobrachys jingzhao. The parent peptide displayed nominal selectivity over the skeletal muscle NaV1.4 channel. Attribute-based positional scan analoging identified a key Ile28Glu mutation that improved NaV1.4 selectivity over 100-fold, and further optimization yielded the potent and selective peptide leads AM-8145 and AM-0422. NMR analyses revealed that the Ile28Glu substitution changed peptide conformation, pointing to a structural rationale for the selectivity gains. AM-8145 and AM-0422 as well as GpTx-1 and HwTx-IV competed for ProTx-II binding in HEK293 cells expressing human NaV1.7, suggesting that these NaV1.7 inhibitory peptides interact with a similar binding site. AM-8145 potently blocked native tetrodotoxin-sensitive (TTX-S) channels in mouse dorsal root ganglia (DRG) neurons, exhibited 30- to 120-fold selectivity over other human TTX-S channels and exhibited over 1,000-fold selectivity over other human tetrodotoxin-resistant (TTX-R) channels. Leveraging NaV1.7-NaV1.5 chimeras containing various voltage-sensor and pore regions, AM-8145 mapped to the second voltage-sensor domain of NaV1.7. AM-0422, but not the inactive peptide analog AM-8374, dose-dependently blocked capsaicin-induced DRG neuron action potential firing using a multi-electrode array readout and mechanically-induced C-fiber spiking in a saphenous skin-nerve preparation. Collectively, AM-8145 and AM-0422 represent potent, new engineered NaV1.7 inhibitory peptides derived from the JzTx-V scaffold with improved NaV selectivity and biological activity in blocking action potential firing in both DRG neurons and C-fibers.

SUBMITTER: Moyer BD 

PROVIDER: S-EPMC5933747 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.

Moyer Bryan D BD   Murray Justin K JK   Ligutti Joseph J   Andrews Kristin K   Favreau Philippe P   Jordan John B JB   Lee Josie H JH   Liu Dong D   Long Jason J   Sham Kelvin K   Shi Licheng L   Stöcklin Reto R   Wu Bin B   Yin Ruoyuan R   Yu Violeta V   Zou Anruo A   Biswas Kaustav K   Miranda Les P LP  

PloS one 20180503 5


Identification of voltage-gated sodium channel NaV1.7 inhibitors for chronic pain therapeutic development is an area of vigorous pursuit. In an effort to identify more potent leads compared to our previously reported GpTx-1 peptide series, electrophysiology screening of fractionated tarantula venom discovered the NaV1.7 inhibitory peptide JzTx-V from the Chinese earth tiger tarantula Chilobrachys jingzhao. The parent peptide displayed nominal selectivity over the skeletal muscle NaV1.4 channel.  ...[more]

Similar Datasets

| S-EPMC7808416 | biostudies-literature
| S-EPMC5848165 | biostudies-literature
| S-EPMC5016110 | biostudies-literature
| S-EPMC5247677 | biostudies-literature
| S-EPMC7210961 | biostudies-literature
| S-EPMC5206724 | biostudies-literature
| S-EPMC4933158 | biostudies-literature
| S-EPMC5308247 | biostudies-literature
| S-EPMC4904248 | biostudies-literature
| S-EPMC3949122 | biostudies-literature